High HIV-1 diversity in immigrants resident in Italy (2008–2017)Maria Teresa Maggiorella, Giulio Starnini, Gabriella d’Ettorre et al.|Scientific Reports|2020Cited by 13
VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimenVelia Chiara Di Maio, Sergio Babudieri, M. Aragri et al.|Digestive and Liver Disease|2020Cited by 1
Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experienceVelia Chiara Di Maio, C. Paternoster, M. Aragri et al.|Digestive and Liver Disease|2019Cited by 0
P-30 Switch from ibalizumab to lenacapavir in a salvage therapy for a patient with multidrug-resistant HIV infectionSalvatore Martini, Nicola Coppola, Nunzia Cuomo et al.|Poster|2024Cited by 0
TD-9 Exploring the use of darunavir boosted plus dolutegravir in highly treatment-experienced HIV population: a retrospective Cohort studyAndrea De Vito, Antonio Di Biagio, Gisele Pedroso Moi et al.|Unknown|2024Cited by 0